HCA
RXII

Harbour Capital Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Harbour Capital Advisors’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-114,350
Closed -$236K – 222
2014
Q3 		$236K Buy
114,350
+18,000
+19% +$37.1K 0.2% 154
2014
Q2 		$295K Buy
96,350
+17,900
+23% +$54.8K 0.23% 151
2014
Q1 		$196K Buy
+78,450
New +$196K 0.19% 150

Other funds holding RXII

BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TIAA CREF Investment Management
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Harbour Capital Advisors's RXII Position: Q4 2014 in Review

Harbour Capital Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2014, closing a stake of 114,350 shares — an estimated $236K sold.

Harbour Capital Advisors first reported a position in RXII in Q1 2014 and held it in 3 quarters. The position peaked at $295K in Q2 2014. 79 funds tracked by Wall St. Rank hold RXII as of Q4 2014.

  • Harbour Capital Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2014 after selling out during the quarter.
  • Harbour Capital Advisors sold 114,350 GALENA BIOPHARMA INC COM shares in Q4 2014, an estimated $236K.
  • Harbour Capital Advisors first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 3 quarters.
  • Harbour Capital Advisors's GALENA BIOPHARMA INC COM position peaked at $295K in Q2 2014.
  • 79 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2014.

Based on Harbour Capital Advisors's 13F filing for Q4 2014, filed 5 Dec 2016.